Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is common in cystic fibrosis (CF). Treatment is challenging and the relapse rate is high. Standard therapy is oral steroids and antifungals. However, long‐term systemic steroid often results in adverse effects and drug interactions between azoles and CF...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyle, Maeve, Mulrennan, Siobhain, Morey, Sue, Vekaria, Sona, Popowicz, Natalia, Tai, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710627/
https://www.ncbi.nlm.nih.gov/pubmed/33304594
http://dx.doi.org/10.1002/rcr2.696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710627/
https://www.ncbi.nlm.nih.gov/pubmed/33304594
http://dx.doi.org/10.1002/rcr2.696

Ejemplares similares